Cambridge scientists have developed a new way to fortify shellfish to tackle human nutrient deficiencies which cause severe health problems across the world. The team is now working with major seafood manufacturers to further test their microencapsulation technology, or “Vitamin Bullets”.
A protein activated by vitamin D could be involved in repairing damage to myelin in people with multiple sclerosis (MS), according to new research from the University of Cambridge. The study, published today in the Journal of Cell Biology, offers significant evidence that vitamin D could be a possible treatment for MS in the future.
As many as one in ten people in Britain over forty years old may be vitamin D deficient, according to a study carried out by researchers at the University of Cambridge.
New research which examined data from nearly 100 studies shows that vitamin D supplementation, when administered alone, does not reduce mortality among older adults.
© 2025 University of Cambridge